ALEXANDRIA, Va., March 5 -- United States Patent no. 12,241,100, issued on March 4, was assigned to SYNTIS BIO INC. (Boston).
"Engineered leucine decarboxylases" was invented by Joyce Liu (Fremont, Calif.), Leann Quertinmont Teadt (Redwood City, Calif.), Nikki Dellas (San Carlos, Calif.), Stephan Jenne (Foster City, Calif.), Faye Loan Du (San Jose, Calif.), Kristen Jean Vallieu (Union City, Calif.) and Kerryn McCluskie (Pacifica, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides engineered leucine decarboxylase (LDC) polypeptides and compositions thereof, as well as polynucleotides encoding the engineered leucine decarboxylase (LDC) polypeptides. In some embodiments, the en...